Amryt announces the signing of a distribution agreement with Medison Pharma Canada (“Medison”) to distribute Myalept (metreleptin) in Canada.
AstraZeneca has announced that it has entered into a definitive agreement with Aegerion Pharmaceuticals, Inc. to divest Myalept (metreleptin for...
The FDA has approved Myalept (metreleptin for injection), from AstraZeneca, which is indicated as an adjunct to diet as replacement...
Novelion Therapeutics announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for Myalept (metreleptin) as...
Amryt provides an update on its engagement with the FDA on Myalept and its proposed development plan and study design to support an indication for patients with partial lipodystrophy (PL).
Amryt, a biopharmaceutical company focused on rare and orphan diseases, announces that it has reached agreement to acquire Aegerion Pharmaceuticals...
Aegerion Pharmaceuticals, Inc.and QLT Inc. have announced that they have entered into a definitive merger agreement under which Aegerion will...